Putnam Investments’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $290K | Buy |
|
|||||
|
2022
Q2 | $397K | Sell |
|
|||||
|
2022
Q1 | $448K | Sell |
|
|||||
|
2021
Q4 | $493K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $6.5M | Sell |
|
|||||
|
2016
Q4 | $8.43M | Buy |
|
|||||
|
2016
Q3 | $6.39M | Sell |
|
|||||
|
2016
Q2 | $4.5M | Buy |
|
|||||
|
2016
Q1 | $3.77M | Buy |
|
|||||
|
2015
Q4 | $7.49M | Buy |
|
|||||
|
2015
Q3 | $4.25M | Buy |
|
|||||
|
2015
Q2 | $3.17M | Buy |
|